Novartis: OmalizumabAchieved all Targets in Phase III Safety Registration

Novartis: OmalizumabAchieved all Targets in Phase III Safety Registration

An announcement made by the Swiss drugmaker Novartis AG (NVS: Quote) on Wednesday suggested about the late-breaking results omalizumab clearing all the primary and secondary endpoints of a pivotal Phase III safety registration study in chronic spontaneous urticaria or CSU.

It is a chronic and debilitating form of hives with partial approved treatment options. GLACIAL is considered as the second of three pivotal Phase III studies. These studies conduct analysis about the efficacy and safety of omalizumab in CSU.

The result derived from the study supported supported the efficacy, safety and tolerability of omalizumab in patients with refractory CSU. It is a kind of chronic and debilitating skin disease with obstinate itch and hives.

Near about 40 percent of CSU patients were unsuccessful on ntihistamines. These include those who were taking the approved dose even for the fourth time. The doses, in terms of official regulations are currently available only for treatment for CSU.

However, Omalizumab is presently not at all approved or indicated for CSU. Supervision of the submissions for omalizumab in CSU is scheduled for later times in the current year. It is a collaborated effort of Novartis and Genentech, Inc.

The data was brought forward for the first time at the European Academy of Allergy and Clinical Immunology-World Allergy Organization World Allergy and Asthma Congress 2013 in Milan which is located in Italy.


FrenchTribune Specials

Alan Eustace creates New World Record for High-Altitude Skydiving

The New York Times has reported that Senior VP at Search Engine Google, Alan Eustace created a new world record for a parachute jump on Friday. Earlier, the record under this category was set in October 2012 by Felix Baumgartner.

Alan broke the earlier set world record when he jumped on earth from the edge of the stratosphere, more than...

Most Popular

Toyota sells partial stake in Tesla Motors

In a recent announcement, world's biggest automaker...

‘PhotoMath’ – a free mobile which can solve mathematical problems almost instant

London-based MicroBlink's 'PhotoMath' free mobile app is...

Soft drinks increases aging process at the same rate as cigarettes

Drinking sodas and smoking cigarettes both accelerate...

Brain-eating amoeba in water supply leads to indictment of two employees

Two workers at Saint John the Baptist Parish in New...

Poll

Can Greece Come out of Economic Problems: